Functional Availability of ON-Bipolar Cells in the Degenerated Retina: Timing and Longevity of an Optogenetic Gene Therapy
Degenerative diseases of the retina are responsible for the death of photoreceptors and subsequent loss of vision in patients. Nevertheless, the inner retinal layers remain intact over an extended period of time, enabling the restoration of light sensitivity in blind retinas via the expression of op...
Guardado en:
Autores principales: | , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cabb37ec0c264beb8e9f7eb8c7b3d0f2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:cabb37ec0c264beb8e9f7eb8c7b3d0f2 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:cabb37ec0c264beb8e9f7eb8c7b3d0f22021-11-11T16:58:30ZFunctional Availability of ON-Bipolar Cells in the Degenerated Retina: Timing and Longevity of an Optogenetic Gene Therapy10.3390/ijms2221115151422-00671661-6596https://doaj.org/article/cabb37ec0c264beb8e9f7eb8c7b3d0f22021-10-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/21/11515https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067Degenerative diseases of the retina are responsible for the death of photoreceptors and subsequent loss of vision in patients. Nevertheless, the inner retinal layers remain intact over an extended period of time, enabling the restoration of light sensitivity in blind retinas via the expression of optogenetic tools in the remaining retinal cells. The chimeric Opto-mGluR6 protein represents such a tool. With exclusive ON-bipolar cell expression, it combines the light-sensitive domains of melanopsin and the intracellular domains of the metabotropic glutamate receptor 6 (mGluR6), which naturally mediates light responses in these cells. Albeit vision restoration in blind mice by Opto-mGluR6 delivery was previously shown, much is left to be explored in regard to the effects of the timing of the treatment in the degenerated retina. We performed a functional evaluation of Opto-mGluR6-treated murine blind retinas using multi-electrode arrays (MEAs) and observed long-term functional preservation in the treated retinas, as well as successful therapeutical intervention in later stages of degeneration. Moreover, the treatment decreased the inherent retinal hyperactivity of the degenerated retinas to levels undistinguishable from healthy controls. Finally, we observed for the first time micro electroretinograms (mERGs) in optogenetically treated animals, corroborating the origin of Opto-mGluR6 signalling at the level of mGluR6 of ON-bipolar cells.Jakub KralikSonja KleinlogelMDPI AGarticleoptogenetic gene therapymGluR6Opto-GPCRsvision restorationretinal degenerationON-bipolar cellsBiology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 11515, p 11515 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
optogenetic gene therapy mGluR6 Opto-GPCRs vision restoration retinal degeneration ON-bipolar cells Biology (General) QH301-705.5 Chemistry QD1-999 |
spellingShingle |
optogenetic gene therapy mGluR6 Opto-GPCRs vision restoration retinal degeneration ON-bipolar cells Biology (General) QH301-705.5 Chemistry QD1-999 Jakub Kralik Sonja Kleinlogel Functional Availability of ON-Bipolar Cells in the Degenerated Retina: Timing and Longevity of an Optogenetic Gene Therapy |
description |
Degenerative diseases of the retina are responsible for the death of photoreceptors and subsequent loss of vision in patients. Nevertheless, the inner retinal layers remain intact over an extended period of time, enabling the restoration of light sensitivity in blind retinas via the expression of optogenetic tools in the remaining retinal cells. The chimeric Opto-mGluR6 protein represents such a tool. With exclusive ON-bipolar cell expression, it combines the light-sensitive domains of melanopsin and the intracellular domains of the metabotropic glutamate receptor 6 (mGluR6), which naturally mediates light responses in these cells. Albeit vision restoration in blind mice by Opto-mGluR6 delivery was previously shown, much is left to be explored in regard to the effects of the timing of the treatment in the degenerated retina. We performed a functional evaluation of Opto-mGluR6-treated murine blind retinas using multi-electrode arrays (MEAs) and observed long-term functional preservation in the treated retinas, as well as successful therapeutical intervention in later stages of degeneration. Moreover, the treatment decreased the inherent retinal hyperactivity of the degenerated retinas to levels undistinguishable from healthy controls. Finally, we observed for the first time micro electroretinograms (mERGs) in optogenetically treated animals, corroborating the origin of Opto-mGluR6 signalling at the level of mGluR6 of ON-bipolar cells. |
format |
article |
author |
Jakub Kralik Sonja Kleinlogel |
author_facet |
Jakub Kralik Sonja Kleinlogel |
author_sort |
Jakub Kralik |
title |
Functional Availability of ON-Bipolar Cells in the Degenerated Retina: Timing and Longevity of an Optogenetic Gene Therapy |
title_short |
Functional Availability of ON-Bipolar Cells in the Degenerated Retina: Timing and Longevity of an Optogenetic Gene Therapy |
title_full |
Functional Availability of ON-Bipolar Cells in the Degenerated Retina: Timing and Longevity of an Optogenetic Gene Therapy |
title_fullStr |
Functional Availability of ON-Bipolar Cells in the Degenerated Retina: Timing and Longevity of an Optogenetic Gene Therapy |
title_full_unstemmed |
Functional Availability of ON-Bipolar Cells in the Degenerated Retina: Timing and Longevity of an Optogenetic Gene Therapy |
title_sort |
functional availability of on-bipolar cells in the degenerated retina: timing and longevity of an optogenetic gene therapy |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/cabb37ec0c264beb8e9f7eb8c7b3d0f2 |
work_keys_str_mv |
AT jakubkralik functionalavailabilityofonbipolarcellsinthedegeneratedretinatimingandlongevityofanoptogeneticgenetherapy AT sonjakleinlogel functionalavailabilityofonbipolarcellsinthedegeneratedretinatimingandlongevityofanoptogeneticgenetherapy |
_version_ |
1718432203676844032 |